PHARMA ANS

  1. The central nervous system (CNS) is the body’s primary nervous system, consisting of the ___ and ___.
    brain and spinal cord
  2. The peripheral nervous system (PNS), located outside the brain and spinal cord, is made up of two divisions:
    • 1. the autonomic
    • 2. the somatic
  3. Also called the visceral system, acts on smooth muscles and glands.
    Autonomic nervous system (ANS)
  4. Its functions include control and regulation of the heart, respiratory system, gastrointestinal tract, bladder, eyes, and glands.
    Autonomic nervous system (ANS)
  5. an involuntary nervous system over which we have little or no control.
    Autonomic nervous system (ANS)
  6. is a voluntary system that innervates skeletal muscles, over which there is control.
    Somatic nervous system (SNS)
  7. Two set of neurons in autonomic component of PNS
    • Afferent or Sensory neurons
    • Efferent or Motor neurons
  8. send impulses to the CNS, where they are interpreted.
    Afferent or Sensory neurons
  9. receive the impulses (information) from the brain and transmit these impulses through the spinal cord to the effector organ cells.
    Efferent or Motor neurons
  10. The efferent pathways in the ANS are divided into two branches
    • Sympathetic nerve
    • Parasympathetic nerve
  11. Also called the adrenergic system
    Sympathetic NS
  12. is the neurotransmitter that innervates smooth muscles.
    Norepinephrine
  13. is released from the terminal nerve ending and
    stimulates the cell receptors to produce response.
    Norepinephrine
  14. Adrenergic receptor organ cells are of four types:
    • Alpha 1
    • Alpha 2
    • Beta 1
    • Beta 2
  15. The sympathetic and parasympathetic nervous systems act on the ___ organs but produce ___ responses to provide ___ (___)
    same; opposite; homeostasis; balance
  16. Drugs that stimulate the sympathetic nervous system are called ___ ___ because they mimic the sympathetic neurotransmitters norepinephrine and epinephrine.
    adrenergic agonists
  17. Increases force of heart contraction; vasoconstriction increases blood pressure; mydriasis (dilation of pupils) occurs; decreases secretion in salivary glands; increases urinary bladder relaxation and urinary sphincter contraction
    Alpha 1
  18. Inhibits release of norepinephrine; dilates blood vessels; produces hypotension; decreases gastrointestinal motility and tone
    Alpha 2
  19. Increases heart rate and force of contraction; increases renin secretion, which increases blood pressure
    Beta 1
  20. Dilates bronchioles; promotes gastrointestinal and uterine relaxation; promotes increase in blood sugar through glycogenolysis in liver;
    increases blood flow in skeletal muscles
    Beta 2
  21. When these receptors in vascular tissues (vessels) of muscles are stimulated, the arterioles and venules constricts; this increase peripheral resistance and blood return to the heart, circulation improves, and blood pressure is increased. When too much stimulation occurs, blood flow decreased to the vital organs.
    Alpha 1
  22. These receptors are in the postganglionic sympathetic nerve endings, when stimulated, they inhibit the release of norepinephrine, which leads to a decrease in vasoconstriction. This results in vasodilation and a decrease in blood pressure.
    Alpha 2
  23. Receptors are located primarily in the heart but are also found in the kidneys. Stimulation of this receptor increase myocardial contractility and heart rate
    Beta 1
  24. Receptors are found mostly in the smooth
    muscle of the lung and GI tract, the liver, and
    the uterine muscle.
    Beta 2
  25. These receptors:
    1. Relaxation of the smooth muscles of the
    lungs which results in bronchodilation
    2. A decrease in GI tone and motility
    3. Activation of glycogenolysis in the liver and
    increase blood glucose.
    4. Relaxation of the uterine muscles, which results in a decreased uterine contraction
    Beta 2
  26. Other adrenergic receptor is ___ and are located in the renal, mesenteric, coronary, and cerebral arteries. When these receptor are stimulated, the vessels dilate and blood flow increases.
    dopaminergic
  27. Other adrenergic receptor is dopaminergic and are located in the renal, mesenteric, coronary, and cerebral arteries. When these receptor are stimulated, the vessels dilate and blood flow increases. Only ___ can activate this receptor.
    dopamine
  28. Transmitters are inactivated by:
    • (1) reuptake of the transmitter back into the neuron (nerve cell terminal),
    • (2) enzymatic transformation or degradation,
    • (3) diffusion away from the receptor.
  29. The two enzymes that inactivate norepinephrine are:
    • (1) monoamine oxidase (MAO), which is inside the neuron; and
    • (2) catechol-O-methyltransferase (COMT), which is outside of the neuron.
  30. Classification of Sympathomimetics
    • Direct-acting sympathomimetics
    • Indirect-acting sympathomimetics
    • mixed-acting sympathomimetics
  31. which directly stimulate the adrenergic receptor (e.g., epinephrine or norepinephrine)
    Direct-acting sympathomimetics
  32. which stimulate the release of norepinephrine from the terminal nerve endings (e.g., amphetamine)
    Indirect-acting sympathomimetics
  33. which stimulate the adrenergic receptor sites and stimulate the release of norepinephrine from the terminal nerve endings
    mixed-acting sympathomimetics
  34. is an example of a mixed-acting sympathomimetic.
    This drug acts indirectly by stimulating the release of norepinephrine from the nerve terminals and acts directly on the alpha1 and beta1 receptors.
    It increases heart rate. It is not as potent a vasoconstrictor as epinephrine, and there is less risk of hemorrhagic stroke and hypertensive crisis.
    Pseudoephedrine
  35. is helpful to relieve nasal and sinus congestion without rebound congestion.
    Pseudoephedrine
  36. are the chemical structures of a substance (either endogenous or synthetic) that can produce a sympathomimetic response.
    Catecholamines
  37. From what category of catecholamines do these belong:
    epinephrine, norepinephrine, and dopamine
    endogenous catecholamines
  38. From what category of catecholamines do these belong:
    isoproterenol and dobutamine
    synthetic catecholamines
  39. stimulate the adrenergic receptors. Most of them have a longer duration of action than the endogenous or synthetic catecholamines.
    Non catecholamines
  40. (Adrenalin), which acts on alpha1-, beta1-, and beta2- adrenergic receptor sites. The responses from these receptor sites include increase in blood pressure, pupil dilation, increase in heart rate (tachycardia), and bronchodilation.
    Epinephrine
  41. In anaphylactic shock, ___ is useful because it increase blood pressure, heart rate, and airflow through the lungs.
    epinephrine
  42. Because epinephrine affects different adrenergic receptors, it is ___.
    nonselective
  43. a beta2-adrenergic agonist, is selective for beta2-adrenergic receptors, so the response is relaxation of bronchial smooth muscle and bronchodilation.
    Albuterol sulfate
  44. action is more selective (activates only the beta2 receptors). By using selective sympathomimetics, fewer undesired adverse effects will occur However, high dosages of this may affect beta1 receptors, causing an increase in heart rate.
    Albuterol sulfate
  45. ✓ is a selective alpha2-adrenergic agonist (sympathomimetic) used primarily to treat hypertension.
    Clonidine
  46. ✓ Alpha2 drugs act by decreasing the release of norepinephrine from sympathetic nerves and decreasing peripheral adrenergic receptor activation.
    Clonidine
  47. ✓ Alpha2 drugs also produce vasodilation by stimulating alpha2 receptors in the central nervous system (CNS), leading to a decrease in blood pressure
    Clonidine
  48. ✓ is an alpha-adrenergic agonist (sympathomimetic) that acts within the CNS.
    Methyldopa
  49. ✓This drug is taken up into the brainstem neurons and converted to methylnorepinephrine, which is an alpha2-adrenergic agonist that leads to alpha2 activation.
    Methyldopa
  50. ✓ The decrease of sympathetic outflow from the CNS causes vasodilation and a reduction in blood pressure
    Methyldopa
  51. Drugs that block the effects of adrenergic neurotransmitters
    Adrenergic Antagonist
  52. They act as antagonists to adrenergic agonists by blocking the alpha and beta receptor sites.
    Adrenergic Blockers
  53. Most adrenergic blockers block either the alpha
    receptor or the beta receptor. They block the effects of the neurotransmitter either directly by occupying the receptors or indirectly by inhibiting the release of the neurotransmitters norepinephrine and epinephrine.
    Sympatholytic
  54. Drugs that block or inhibit a response at the alpha-adrenergic receptor site
    Alpha-adrenergic Antagonist
  55. Alpha-blocking agents are divided into two groups:
    • 1. selective alpha blockers that block alpha1,
    • 2. nonselective alpha blockers that block alpha1 and alpha2.
  56. promote vasodilation, causing a decrease in blood pressure.
    Alpha antagonists (alpha blockers)
  57. If vasodilation is long-standing, ___ ___ can result.
    orthostatic hypotension
  58. ___ may also be a symptom of a drop in blood pressure.
    Dizziness
  59. As blood pressure decreases, pulse rate usually ___ to compensate for the low blood pressure and inadequate blood flow.
    increases
  60. ___ ___can be used to treat peripheral vascular disease (e.g., Raynaud’s disease).
    Alpha antagonists
  61. These drugs are also helpful in decreasing symptoms of benign prostatic hyperplasia.
    Alpha antagonists
  62. Commonly called beta blockers, decrease heart rate, and a decrease in blood pressure usually follows.
    Beta-adrenergic antagonists
  63. Some beta blockers are nonselective, blocking both beta1 and beta2 receptors. Not only does the heart rate decrease because of beta1 blocking, but ___ also occurs.
    bronchoconstriction
  64. Nonselective beta blockers (block both beta1 and beta2) should be used with extreme caution in any patient who has ___ or ___.
    chronic obstructive pulmonary disease (COPD); asthma
  65. was the first beta blocker prescribed to treat angina, cardiac dysrhythmias, hypertension, and heart failure.
    Propanolol hydrochloride
  66. This medication is given for migraine prophylaxis.
    Propanolol hydrochloride
  67. is the ability of certain beta blockers to bind with a beta receptor to prevent strong agonists from binding to that receptor producing complete activation.
    Intrinsic sympathomimetic activity
  68. The selective blocker (blocks beta1 only) that has ISA is ___
    acebutolol
  69. a selective Beta blocker, decreases sympathetic outflow to the periphery and suppresses the renin-angiotensin-aldosterone system (RAAS) response.
    Atenolol
  70. It is contraindicated in bradycardia, heart block, cardiogenic shock, acute heart failure, asthma, and sick sinus syndrome.
    Atenolol
  71. Beta-adrenergic Antagonists should not be abruptly discontinued but rather should be tapered off over __ to __ weeks to avoid tachycardia, HPN, severe angina, dysrhythmia and MI.
    1 to 2 weeks
  72. Atenolol has a half life of __ to __ hours and is eliminated in urine
    6 to 7
  73. The use od decongestants with epinephrine has an ___ effect.
    addictive
  74. ___ can antagonize the action of epinephrine.
    Beta-blockers
  75. ___ and ___ allow epinephrine effects to be intensified and prolonged.
    TCA’s; MAOIs
  76. For Atenolol, the onset of action of the oral preparation is __ hour; peak time is __ to __ hours, and duration of action is __ hours. This drug is effective for dosing __ a day, especially for patients who do not adhere to schedules that require dosing several times a day.
    1 hour; 2 to 4 hours; 24; once
  77. ___decrease the hypotensive effect of atenolol.
    nonsteroidal anti-inflammatory drugs (NSAIDs)
  78. When atenolol is given concurrently with ___ and other anticholinergics, absorption is increased.
    atropine
  79. Drugs that block the release of norepinephrine from the sympathetic terminal neurons, which are classified as a subdivision of the adrenergic blockers.
    Adrenergic Neuron Antagonists
  80. Two groups of drugs affect the parasympathetic nervous system they include:
    • 1. Cholinergic agonists
    • 2. Cholinergic antagonists
  81. muscarinic agonists or parasympathomimetics
    Cholinergic agonists
  82. (blocking agent)-muscarinic antagonists, parasympatholytic or commonly called anticholinergics.
    Cholinergic antagonists
  83. The parasympathetic nervous system is called the ___ system because the neurotransmitter at the end of the neuron that innervates the muscle is ___.
    cholinergic system; acetylcholine
  84. The cholinergic receptors at organ cells are either ___ or ___,
    nicotinic or muscarinic- meaning that they are stimulated by the alkaloids nicotine and muscarine, respectively.
  85. Acetylcholine stimulates the receptor cells to produce a response, but the enzyme ___ may inactivate acetylcholine before it reaches the receptor cell.
    acetylcholinesterase
  86. Drugs that mimics the neurotransmitters norepinephrine and acetylcholine produce responses ___ to each other on the same organ.
    opposite
  87. Drugs that stimulates the PNS are called ___ ___, or ___, because they mimic the parasympathetic neurotransmitter acetylcholine.
    cholinergic agonists; parasympathomimetics
  88. The neurotransmitter located at the ganglions and the parasympathetic terminal nerve endings.
    -it innervates cholinergic receptors on organs, tissues, and glands.
    Acetylcholine (aCh)
  89. Two types of cholinergic receptors are
    • muscarinic receptors
    • nicotinic receptors
  90. cholinergic receptor which stimulates the smooth muscles and slow the heart rate.
    muscarinic receptors
  91. cholinergic receptor which affects the skeletal muscles.
    nicotinic receptors
  92. The ___ bind the enzyme cholinesterase for several minutes to hours
    reversible inhibitors
  93. ___ bind the enzyme permanently.
    irreversible inhibitors
  94. are primarily selective to the muscarinic receptors but are nonspecific because the muscarinic receptors are located in the smooth muscle of the GI and genitourinary tracts,glands, and heart.
    Direct-acting cholinergic agonists
  95. a direct-acting cholinergic agonist, acts on the muscarinic (cholinergic) receptor and is used primarily to increase micturition (urination) in the treatment of urinary retention and neurogenic bladder.
    Bethanechol chloride
  96. is a direct-acting cholinergic agonist that is usually prescribed to treat gastroesophageal reflux disease (GERD). It accelerates gastric emptying time.
    Metoclopramide HCl
  97. is a direct-acting cholinergic agonist that constricts the pupils of the eyes, thus opening the canal of Schlemm to promote drainage of aqueous humor (fluid).
    Pilocarpine
  98. This drug is used to treat glaucoma by relieving fluid (intraocular) pressure in the eye and to promote miosis in eye surgery and examinations.
    Pilocarpine
  99. Drugs that inhibit the actions of acetylcholine by occupying the acetylcholine receptors are called
    cholinergic antagonists
  100. Was first derived from the belladonna plant (Atropa belladonna) and purified in 1831, is a classic anticholinergic, or muscarinic antagonist drug.
    Atropine sulfate
  101. was the second belladonna alkaloid produced.
    Scopolamine
  102. It is useful primarily
    (1) as a preoperative medication to decrease salivary secretions and
    (2) as an agent to increase heart rate when bradycardia is present.
    Atropine
Author
Lynx
ID
363262
Card Set
PHARMA ANS
Description
Updated